 |
Indication & Dosage |
| |
| |
| Topical/Cutaneous |
| ACNE |
| Adult:
>12 yr: Apply a thin layer of 0.1% cream or gel to cleansed dry affected area, once daily in the evening. |
| |
| Topical/Cutaneous |
| STABLE PLAQUE PSORIASIS |
| Adult:
>18yr: Apply a thin layer of 0.05% or 0.1% cream or gel to cleansed dry affected area, once daily in the evening. If needed, moisturiser should be applied at least 1 hr prior to application of tazarotene. |
| |
| Topical/Cutaneous |
| PHOTOAGING |
| Adult:
>17yr: Apply a thin layer of 0.1% cream or gel to cover entire face (including eyelids) once daily before retiring. |
|
| |
|
| Precautions |
Avoid contact with eyes, mouth, mucous membranes. Abraded skin. Avoid exposure to sun or UV light. Do not use >10% of BSA. Do not use cream with occlusive dressing. Wash hands after application. Do not use cream/gel in amounts more than instructed. Women of child bearing potential should take birth control measures. Negative pregnancy test to be obtained within 2 wk prior to initiation and start therapy during normal menstrual period. |
| |
|
| Adverse Drug Reactions |
Pruritus, burning/stinging, erythema, skin peeling, irritation, worsening of psoriasis, rash, dry skin, bleeding, localised oedema, hypertriglyceridaemia, desquamation, contact dermatitis, discolouration of skin, photosensitivity. |
| |
|
| Interactions |
Increased drying effect effect with concomitant use of dermatologic medications and cosmetics that have irritant or strong drying effect. Increased risk of photosensitivity with drugs known to be photosensitisers. |
| |
|
|
|
